Navigation Links
With the Recent Launch of Novartis's Gilenya, Extavia is Pushed Into the Background of Multiple Sclerosis Treatment One Year After its Launch
Date:12/13/2010

20 of the respondents in November 2010. MS market dynamics will also be measured in upcoming syndicated reports including TreatmentTrends®: Multiple Sclerosis and ChartTrends®: Multiple Sclerosis. BioTrends also recently published the first wave of LaunchTrends®: Gilenya, a report series tracking trial, uptake, and perceptions of Novartis' Gilenya, at one, three and six months post launch. The next wave will be published in February 2011.

About LaunchTrendsLaunchTrends assesses trial and use of new products, obstacles to use, reasons to use, typical patient types, line of therapy, product perceptions, promotional efforts/messages and product satisfaction.

About BioTrends Research Group, Inc.BioTrends Research Group, Inc. (www.bio-trends.com) provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please contact us at (610) 363-3872 or www.bio-trends.com.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks of their respective holders.For more information, contact:BioTrends Research Group, Inc.Sharon Funk404-223-2963sfunk@bio-trends.com   Decision Resources, Inc.Christopher Comfort781-993-2597 ccomfort@dresources.c
'/>"/>

SOURCE BioTrends Research Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
2. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
3. [video] Wall St. Networks 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: IMMU, KYUS
4. [video] Wall St. Networks 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR, BHRT, AGO
5. Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights
6. TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments
7. New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinsons Disease Drug Development
8. Bionovo to Present Recent Findings of BN107, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
9. American Oriental Bioengineering Comments on Recent Property Purchase
10. Recent Advances in Organic Chemistry Using Real-Time In Situ FTIR
11. Recent Reports Regarding Mercury and High Fructose Corn Syrup Flawed and Misleading
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... (PRWEB) May 21, 2013 Many have ... as contributor to acne. Recently physicians from Clinical ... mental stress on the skin, and suggested using ... reduce the chemicals produced from stress that cause acne. ... the negative feelings acne brings about, stress causes changes ...
(Date:5/21/2013)... , May 21, 2013  Personal Genome Diagnostics ... its proprietary methodologies and expertise in genomic analysis ... targets in collaboration with Blueprint Medicines.  PGDx is ... identifying genomic alterations in tumors, and Blueprint Medicines ... inhibitors for a genetically defined patient population. ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Inflamax ... of the ITN to design the study, which ... two key clinical models used in the study ... and Nasal Allergen Challenge (NAC) models. Although both ... numerous publications, to date no direct comparison between ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 PathoGenetix, Inc., ... bacterial strain typing, announced today that it has successfully ... E. coli strains obtained from the Centers for Disease ... Scanning™ (GSS™) technology. The findings are detailed in a ... the American Society for Microbiology in Denver on Monday. ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3
... SkinHealth Technology introduces a skin animation video depicting the ... Treatment Balm on skin affected with psoriasis. ... Psoriasis treatment The powerful, ... and botanical emollients -- with a proven skin protectant ...
... of Technology have for the first time provided ... growing high-quality layers of epitaxial graphene on silicon ... vapor pressure of gas-phase silicon in the high-temperature ... basic principle for growing thin layers of graphene ...
... 2011 SuperNova Diagnostics®, Inc., a privately-held global diagnostics ... that Neil J. Campbell, president and CEO, will be ... D.C. on September 27, 2011 at 11:00 a.m. in ... in Washington, D.C.   The presentation will ...
Cached Biology Technology:Skin Animation Highlights New Dermatological Formula That Targets Psoriasis 2Controlling silicon evaporation allows scientists to boost graphene quality 2Controlling silicon evaporation allows scientists to boost graphene quality 3SuperNova Diagnostics® to Present at AdvaMed 2011: The Medtech Conference in Washington, D.C. 2
(Date:5/19/2013)... have engineered a strain of electricity-producing bacteria that can ... and carbon dioxide as its sole source of carbon. ... their findings at the 113th General Meeting of the ... result of current production solely on hydrogen," says Amit ... his co-authors are part of the Lovley Lab Group ...
(Date:5/18/2013)... presented today at Digestive Disease Week (DDW) explores new ... impact of coffee on autoimmune disease and palliative care ... has been associated with reduced risk of fibrosis, a ... of java each month also correlate with lower risk ... Mayo Clinic, Rochester, MN, linked coffee consumption with reduced ...
(Date:5/17/2013)... Research Foundation announced a new grant that intends to ... one of today,s most exciting areas of science, and ... Awards Panel selected Andrew T. Chan, MD, MPH and ... School, Boston, as the 2013 AGA-Elsevier Gut Microbiome Pilot ... funding, commencing in July 2013, to test the overarching ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2
... Reportlinker.com announces that a new market research ... Biometrics: Technologies and Global Markets ... report studies the global as well as regional markets ... locating newer markets and expanding the present market position ...
... If you,re unsure about what foods to eat to maintain ... to point people back to basics and reach for ... edition of American Journal of Clinical Nutrition reveals ... to an 18% decreased risk of cardiovascular disease. The ...
... TEMPE, Ariz. Enormous uncertainty. These two words ... in the 21st century. Reservoirs have dipped to their ... forecasts for even warmer summers are predicted. Despite this ... need to be fearful because positive impacts can be ...
Cached Biology News:Reportlinker Adds Biometrics: Technologies and Global Markets 2Reportlinker Adds Biometrics: Technologies and Global Markets 3Reportlinker Adds Biometrics: Technologies and Global Markets 4Reportlinker Adds Biometrics: Technologies and Global Markets 5Reportlinker Adds Biometrics: Technologies and Global Markets 6Reportlinker Adds Biometrics: Technologies and Global Markets 7Reportlinker Adds Biometrics: Technologies and Global Markets 8Reportlinker Adds Biometrics: Technologies and Global Markets 9Reportlinker Adds Biometrics: Technologies and Global Markets 10Reportlinker Adds Biometrics: Technologies and Global Markets 11Reportlinker Adds Biometrics: Technologies and Global Markets 12Reportlinker Adds Biometrics: Technologies and Global Markets 13Reportlinker Adds Biometrics: Technologies and Global Markets 14Reportlinker Adds Biometrics: Technologies and Global Markets 15Reportlinker Adds Biometrics: Technologies and Global Markets 16Reportlinker Adds Biometrics: Technologies and Global Markets 17Reportlinker Adds Biometrics: Technologies and Global Markets 18Reportlinker Adds Biometrics: Technologies and Global Markets 19Reportlinker Adds Biometrics: Technologies and Global Markets 20Reportlinker Adds Biometrics: Technologies and Global Markets 21Reportlinker Adds Biometrics: Technologies and Global Markets 22Go ahead, drink your milk 2A positive step in the face of uncertainty 2
Anti-MMP-19 (RASI), carboxy terminal region; rabbit host...
Rabbit polyclonal to MAP3K12 ( Abpromise for all tested applications). Antigen: Synthetic peptide conjugated to KLH from the C-terminal region of human MAP3K12 Entrez Gene ID: 7786 Swiss ...
Phosphatidylinositol transfer protein beta isoform (PtdIns transfer protein beta) (PtdInsTP) (PI-TP-beta). [Source:Uniprot/SWISSPROT;Acc:P48739] Antigen: Recombinant Protein Epitope Signature Tag...
Desmosomal Protein Immunogen: Full length, native protein purified from human epidermal keratins. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: